Latest Qiming U.S. Ventures Management, LLC Stock Portfolio
Qiming U.S. Ventures Management, LLC Performance:
2025 Q2: 7.56%YTD: -27.52%2024: -22.13%
Performance for 2025 Q2 is 7.56%, and YTD is -27.52%, and 2024 is -22.13%.
About Qiming U.S. Ventures Management, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, QIMING U.S. VENTURES MANAGEMENT, LLC reported an equity portfolio of $23.6 Millions as of 30 Jun, 2025.
The top stock holdings of QIMING U.S. VENTURES MANAGEMENT, LLC are , JSPR, . The fund has invested 50.2% of it's portfolio in TOURMALINE BIO INC and 21.8% of portfolio in JASPER THERAPEUTICS INC.
The top stock holdings of QIMING U.S. VENTURES MANAGEMENT, LLC are , JSPR, . The fund has invested 50.2% of it's portfolio in TOURMALINE BIO INC and 21.8% of portfolio in JASPER THERAPEUTICS INC.
Qiming U.S. Ventures Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that QIMING U.S. VENTURES MANAGEMENT, LLC made a return of 7.56% in the last quarter. In trailing 12 months, it's portfolio return was -39.26%.
New Buys
Additions
Reductions
Sold off
Sector Distribution
QIMING U.S. VENTURES MANAGEMENT, LLC has about 69.7% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 69.7 |
| Healthcare | 30.3 |
Market Cap. Distribution
QIMING U.S. VENTURES MANAGEMENT, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 69.7 |
| MICRO-CAP | 28.7 |
| NANO-CAP | 1.6 |
Stocks belong to which Index?
About 8.5% of the stocks held by QIMING U.S. VENTURES MANAGEMENT, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 91.5 |
| RUSSELL 2000 | 8.5 |
Qiming U.S. Ventures Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Qiming U.S. Ventures Management, LLC
QIMING U.S. VENTURES MANAGEMENT, LLC has 6 stocks in it's portfolio. KZR proved to be the most loss making stock for the portfolio. JSPR was the most profitable stock for QIMING U.S. VENTURES MANAGEMENT, LLC last quarter.
Last Reported on: 14 Aug, 2025| Ticker | Namesorted descending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| tourmaline bio inc | 50.22 | 741,691 | 11,859,600 | unchanged | 0.00 | |||
| JSPR | jasper therapeutics inc | 21.83 | 928,964 | 5,155,750 | unchanged | 0.00 | ||
| korro bio inc | 19.47 | 368,085 | 4,597,380 | unchanged | 0.00 | |||
| VTYX | ventyx biosciences inc | 3.73 | 412,225 | 882,162 | unchanged | 0.00 | ||
| HLVX | hillevax inc | 3.14 | 372,615 | 741,504 | unchanged | 0.00 | ||
| KZR | kezar life sciences inc | 1.61 | 82,871 | 379,549 | unchanged | 0.00 | ||
